Effects of gestrinone on uterine leiomyoma and expression of c-Src in a guinea pig model

Acta Pharmacologica Sinica

Volumn 28, Issue 5, 2007, Pages 685-694

  Zhu, Yan ^a,b   Qiu, Xiao Yan ^a,b   Wang, Lei ^b   Wu, Jian Hui ^b   Liu, Gui Ming ^b   He, Gui Lin ^b   Jiang, Xiu Rong ^b   Sun, Zu Yue ^b   Cao, Lin ^b  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF PLANNED PARENTHOOD RESEARCH   (China)

Author keywords

c Src; Estradiol receptor; Gestrinone; Guinea pig; Progesterone receptor; Uterine leiomyoma

Indexed keywords

ESTRADIOL BENZOATE; ESTRADIOL RECEPTOR; GESTRINONE; PROGESTERONE RECEPTOR; PROTEIN TYROSINE KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG EFFICACY; FEMALE; GUINEA PIG; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MYOMETRIUM; NONHUMAN; ONCOGENE SRC; OVARIECTOMY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; RANDOMIZATION; SMOOTH MUSCLE FIBER; TREATMENT DURATION; UTERUS MYOMA; UTERUS WEIGHT; WESTERN BLOTTING;

ANIMALS; FEMALE; GENE EXPRESSION; GESTRINONE; GUINEA PIGS; LEIOMYOMA; MODELS, MOLECULAR; OVARIECTOMY; PROGESTINS; PROTEIN-TYROSINE KINASES; RANDOM ALLOCATION; UTERINE NEOPLASMS; UTERUS;

EID: 34247639043     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00537.x     Document Type: Article

References (47)

1. Cooper NP, Okolo S. Fibroids in pregnancy-common but poorly understood. Obstet Gynecol Surv 2005 60 : 132 8.
2. Myers ER, Barber MD, Gustilo-Ashby T, Couchman G, Matchar DB, McCrory DC. Management of uterine leiomyoma: what do we really know Obstet Gynecol 2002 100 : 8 17.
3. Wilcox LS, Koonin LM, Pokras R, Strauss LT, Xia Z, Peterson HB. Hysterectomy in the United States, 1988-1990. Obstet Gynecol 1994 83 : 549 55.
4. De Leo V, Morgante G, La Marca A, Musacchio MC, Sorace M, Cavicchioli C, et al. A benefit-risk assessment of medical treatment for uterine leiomyomas. Drug Saf 2002 25 : 759 79.
5. Rein MS, Barbieri RL, Friedman AJ. Progesterone: a critical role in the pathogenesis of uterine myomas. J Obstet Gynecol 1995 172 : 14 8.
6. Flake GP, Andersen J, Dixon, D. Etiology and pathogenesis of uterine leiomyomas: A review. Environ Health Perspect 2003 111 : 1037 54.
7. Edwards DP, Boonyaratanakornkit V. Rapid extranuclear signaling by the estradiol receptor (ER): MNAR couples ER and Src to the MAP kinase signaling pathway. Mol Interv 2003 3 : 12 5.
8. McKenna NJ, O'Malley BW. Combinatorial control of gene expression by nuclear receptors and coregulators. Cell 2002 108 : 465 74.
9. Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyoma. Fertil Steril 1991 56 : 997 1000.
10. Shimomura Y, Matsuo H, Samoto T, Maruo T. Up-regulation by progesterone of proliferating cell nuclear antigen and epidermal growth factor expression in human uterine leiomyoma. J Clin Endocrinol Metab 1998 83 : 2192 8.
11. Luo X, Ding L, Xu J, Chegini N. Gene expression profiling of leiomyoma and myometrial smooth muscle cells in response to transforming growth factor-beta. Endocrinology 2005 146 : 1097 118.
12. Englund K, Lindblom B, Carlstrom K, Gustavsson I, Sjoblom P, Blanck A. Gene expression and tissue concentrations of IGF-I in human myometrium and fibroids under different hormonal conditions. Mol Hum Reprod 2000 6 : 915 20.
13. Hunter T, Sefton BM. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc Natl Acad Sci USA 1980 77 : 1311 5.
14. Martin GS. The hunting of the Src. Nat Rev Mol Cell Biol 2001 2 : 467 75.
15. Ishizawar R, Parsons SJ. c-Src and cooperating partners in human cancer. Cancer Cell 2004 6 : 209 14.
16. Thomas SM, Brugge JS. Cellular functions regulated by Src family kinases. Annu Rev Cell Dev Biol 1997 13 : 513 609.
17. Irby RB, Yeatman TJ. Role of Src expression and activation in human cancer. Oncogene 2000 19 : 5636 42.
18. Wiener JR, Windham TC, Estrella VC, Parikh NU, Thall PF, Deavers MT, et al. Activated SRC protein tyrosine kinase is overexpressed in late-stage human ovarian cancers. Gynecol Oncol 2003 88 : 73 9.
19. Bolen JB, Veillette A, Schwartz AM, DeSeau V, Rosen N. Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci USA 1987 84 : 2251 5.
20. Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, et al. c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis. J Pathol 1996 180 : 383 8.
21. Summy JM, Gallick GE. Src family kinases in tumor progression and metastasis. Cancer and metastasis reviews 2003 22 : 337 58.
22. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Auricchio F. Src is an initial target of sex steroid hormone action. Ann N Y Acad Sci 2002 963 : 185 90.
23. Migliaccio A, Castoria G, Di Domenico M, De Falco A, Bilancio A, Lombardi M, et al. Sex steroid hormones act as growth factors. J Steroid Biochem Mol Biol 2003 83 : 31 5.
24. Migliaccio A, Piccolo D, Castoria G, Di Domenico M, Bilancio A, Lombardi M, et al. Activation of the Src/p21ras/Erk pathway by progesterone receptor via cross-talk with estrogen receptor. EMBO J 1998 17 : 2008 18.
25. Kim H, Laing M, Muller W. c-Src-null mice exhibit defects in normal mammary gland development and ER signaling Oncogene 2005 24 : 5629 36.
26. Mora G, Faundes A, Pastore U. Clinical evaluation of an oral progestin contraceptive, r-2323, 5mg, administered at weekly intervals. Contraception 1974 10 : 145 57.
27. Nieto A, Tacuri C, Serra M, Keller J, Cortes-Prieto J. Evaluation of gestrinone after surgery in treatment of endometriosis. Gynecol Obstet Invest 1997 43 : 192 4.
28. Bromham DR, Booker MW, Rose GL, Wardle PG, Newton JR. Updating the clinical experience in endometriosis - the European perspective. Br J Obstet Gynaecol 1995 102 (Suppl 12 12 6.
29. La Marca A, Giulini S, Vito G, Orvieto R, Volpe A, Jasonni VM. Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply. Fertil Steril 2004 82 : 1694 6.
30. Remmele W, Stegner HE. Recommendation for uniform definition of an immunoreactive score (IRS) for immunohistochemical estradiol receptor detection (ER-ICA) in breast cancer tissue. Pathologe 1987 8 : 138 40.
31. Munstedt K, Steen J, Knauf AG. Steroid hormone receptors and long term survival in invasive ovarian cancer. Cancer 2000 89 : 1783 91.
32. Li S, McLachlan JA. Estrogen-associated genes in uterine leiomyoma. Ann N Y Acad Sci 2001, 948 : 112 20.
33. Dawood MY, Khan-Dawood FS. Plasma insulin-like growth factor-I, CA-125, estrogen, and progesterone in women with leiomyomas. Fertil Steril 1994 61 : 617 21.
34. Andersen J, Grine E, Eng CL, Zhao K, Barbieri RL, Chumas JC, et al. Expression of connxin-43 in human myometrium and leiomyoma. Am J Obstet Gynecol 1993 169 : 1266 76.
35. Porter KB, Tsibris JC, Nicosia SV, Murphy JM, O'Brien WF, Rao PS, et al. Estrogen-induced guinea pig model for uterine leiomyomas: do the ovaries protect Biol Reprod 1995 52 : 824 32.
36. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005 308 : 1589 92.
37. Fujii S, Nakashima N, Okamura H, Takenaka A, Kanzaki H, Okuda Y, et al. Progesterone-induced smooth muscle-like cells in the subperitoneal nodules produced by estrogen. Experimental approach to leiomyomatosis peritonealis disseminata. Am J Obstet Gynecol 1981 139 : 164 72.
38. Adams AD, Hild-Petito S, Donnelly K, Fazleabas AT. Regulation of estradiol (E) and progestin (p) receptors (R) in leiomyomas during the cycle and leuprolide acetate treatment. In : Proceedings of the Forty-Ninth Annual Meeting of the American Fertility Society, October 11-14 1993 Quebec, Canada. Montreal : American Fertility Society, 1993. S134.
39. Katzenellenbogen BS. Dynamics of steroid hormone receptor action. Annu Rev Physiol 1980 42 : 17 35.
40. Watson CS, Gametchu B. Membrane-initiated steroid actions and the proteins that mediate them. Proc Soc Exp Biol Med 1999 220 : 9 19.
41. Nemere I, Zhou LX, Norman AW. Nontranscriptional effects of steroid hormones. Receptor 1993 3 : 277 91.
42. Migliaccio A, Di Domenico M, Castoria G, De Falco A, Bontempo P, Nola E, et al. Tyrosine kinase/p21ras/MAP-kinase pathway activation by estradiol-receptor complex in MCF-7 cells. EMBO J 1996 15 : 1292 300.
43. Ballare C, Uhrig M, Bechtold T, Sancho E, Di Domenico M, Migliaccio A, et al. Two domains of the progesterone receptor interact with the estradiol receptor and are required for progesterone activation of the c- Src/Erk pathway in mammalian cells. Mol Cell Biol 2003 23 : 1994 2008.
44. Castoria G, Migliaccio A, Bilancio A, Di Domenico M, De Falco A, Lombardi M, et al. PI3-kinase in concert with Src promotes the S-phase entry of oestradiol-stimulated MCF-7 cells. EMBO J 2001 20 : 6050 9.
45. Castoria G, Barone MV, Di Domenico M, Ametrano D, Migliaccio A, Auricchio F. Non-transcriptional action of oestradiol and progestin triggers DNA synthesis. EMBO J 1999 18 : 2500 10.
46. Cartwright CA, Eckhart W, Simon S, Kaplan P. Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell 1987 49 : 83 91.
47. Morgan DO, Kaplan JM, Bishop JM. Varmus HE. Mitosis specific phosphorylation of pp60 c-src by p34cdc2 associated protein kinase. Cell 1989 57 : 775 86.